✦ LIBER ✦

Single Institution Validation of Risk Adjusted Outcomes for 1 Year Mortality In Pediatric Allogeneic Stem Cell Transplantation (HSCT)

✍ Scribed by R.E. Duerst; T.L. Halverson; N. Reynolds; D. Jacobsohn; A. Rademaker; M. Kletzel

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Second Allogeneic Hematopoietic Stem Cel

✍ Akira Tomonari; Tohru Iseki; Jun Ooi; Hitomi Nagayama; Hiroyuki Sato; Tsutomu Ta 📂 Article 📅 2002 🏛 Carden Jennings Publishing 🌐 English ⚖ 94 KB

237: Long term results of allogeneic ste

✍ V.A.M. Funke; C. Pettengill; C.M. Bonfim; J. Ruiz; A.P. Azambuja; L. Medeiros; D 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Allogeneic hematopoietic stem cell trans

✍ Tohru Nakagawa; Masahiro Kami; Akiko Hori; Sung-Won Kim; Naoko Murashige; Tamae 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 216 KB

Adenovirus (ADV) Infection In Pediatric

✍ N.K. El-Mallawany; D. George; Z. Jin; P. Della-Latta; P. Satwani; J.H. Garvin; M 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 64 KB

213Outcome of pediatric patients who und

✍ M. Kletzel; D. Jacobsobn; R. Duerst 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 124 KB

Impact of Cytogenetics Risk on Outcome A

✍ M. Mohty; M. Labopin; N. Milpied; J.J. Cornelissen; D. Blaise; E. Petersen; N. T 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 59 KB